
Karius
Karius
Claim
Karius provides unique genomic insights by detecting microbial cell-free DNA (mcfDNA) circulating in the bloodstream from pathogens causing an acute infection. Proprietary technology efficiently extracts mcfDNA directly from blood and depletes the strong human background signal and environmental contaminants. Advanced machine learning algorithms allow analysis of complex genomic data in real-time. Proprietary reference genome databases are constantly refined as more data becomes available.Karius provides unique genomic insights by detecting microbial cell-free DNA (mcfDNA) circulating in Show More
Alpha Score
$ 329.00 M
Alpha Score
79.8
Predictions
Overview
Team
Financials
- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0